microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
暂无分享,去创建一个
Tint Lwin | William Kong | Jianguo Tao | Huan Yang | W. Kong | Jian-jun Zhao | J. Cheng | W. Dalton | Jian-ping Guo | L. Moscinski | J. Tao | T. Lwin | E. Sotomayor | William S Dalton | Jianping Guo | Jin Q Cheng | Jianhong Lin | Jianhong Lin | Eduardo Sotomayor | Jian-Jun Zhao | Hua Yang | Sophie Dessureault | Lynn C Moscinski | Dorna Rezania | S. Dessureault | Dorna Rezania
[1] Y. Yatabe,et al. Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival , 2004, Cancer Research.
[2] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[3] Stijn van Dongen,et al. miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..
[4] A. Rosenwald,et al. MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas. , 2009, Cancer research.
[5] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[6] G. Gores,et al. mir-29 regulates Mcl-1 protein expression and apoptosis , 2007, Oncogene.
[7] Thomas D. Schmittgen,et al. Expression profiling identifies microRNA signature in pancreatic cancer , 2006, International journal of cancer.
[8] E. Campo,et al. Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas. , 1997, Blood.
[9] A. Hatzigeorgiou,et al. TarBase: A comprehensive database of experimentally supported animal microRNA targets. , 2005, RNA.
[10] Tara L. Naylor,et al. microRNAs exhibit high frequency genomic alterations in human cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[11] C. Croce,et al. MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.
[12] W. Dalton,et al. Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas. , 2006, Blood.
[13] L. Staudt,et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. , 2003, Cancer cell.
[14] D. Bartel,et al. MicroRNA-Directed Cleavage of HOXB8 mRNA , 2004, Science.
[15] D C Louie,et al. p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). , 1995, Blood.
[16] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[17] E. Noordijk,et al. Mantle-cell lymphoma: a population-based clinical study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] S. Pileri,et al. Mantle Cell Lymphoma. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] Martin Dreyling,et al. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. , 2006, Blood.
[20] Huating Wang,et al. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. , 2008, Cancer cell.
[21] W. Chan,et al. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. , 1996, Blood.
[22] Domenico Coppola,et al. MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer* , 2008, Journal of Biological Chemistry.
[23] C. Croce,et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[24] K. Kosik,et al. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. , 2005, Cancer research.
[25] K. Gunsalus,et al. Combinatorial microRNA target predictions , 2005, Nature Genetics.
[26] Huan Yang,et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. , 2008, Cancer research.
[27] Yvonne Tay,et al. A Pattern-Based Method for the Identification of MicroRNA Binding Sites and Their Corresponding Heteroduplexes , 2006, Cell.
[28] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[29] R. Stephens,et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.
[30] M. Dyer,et al. p73, miR106b, miR34a, and Itch in chronic lymphocytic leukemia. , 2009, Blood.
[31] J. Diebold,et al. THE WORLD HEALTH ORGANIZATION CLASSIFICATION OF HEMATOLOGICAL MALIGNANCIES REPORT OF THE CLINICAL ADVISORY COMMITTEE MEETING , 2000 .
[32] Muller Fabbri,et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.
[33] Hong Xu,et al. MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. , 2009, Cancer research.
[34] Š. Pospíšilová,et al. miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities , 2009, Leukemia.
[35] Jason H. Moore,et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. , 2007, Cancer research.
[36] Claudia Petritsch,et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells , 2008 .
[37] Benjamin Haibe-Kains,et al. microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. , 2009, Blood.
[38] Jin-Wu Nam,et al. miR-29 miRNAs activate p53 by targeting p85α and CDC42 , 2009, Nature Structural &Molecular Biology.
[39] C. Morrison,et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B , 2007, Proceedings of the National Academy of Sciences.
[40] R. Gascoyne,et al. Mantle cell lymphoma: a clinicopathologic study of 80 cases. , 1997, Blood.
[41] F. Doetsch,et al. Stem cells: from epigenetics to microRNAs. , 2005, Neuron.
[42] Reiner Siebert,et al. Identified hidden genomic changes in mantle cell lymphoma using high-resolution single nucleotide polymorphism genomic array. , 2009, Experimental hematology.
[43] Y. Pekarsky,et al. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. , 2006, Cancer research.
[44] F. Doetsch,et al. Stem Cells From Epigeneticsto microRNAs , 2005, Neuron.
[45] C. Bloomfield,et al. The World Health Organization Classification of Hematological Malignancies Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997 , 2000, Modern Pathology.
[46] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[47] William A Robinson,et al. Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. , 2008, Blood.
[48] E. Zucca,et al. Concomitant MYC and microRNA cluster miR-17-92 (C13orf25) amplification in human mantle cell lymphoma , 2007, Leukemia & lymphoma.